Canine Uterine Bacterial Infection Induces Upregulation of Proteolysis-Related Genes and Downregulation of Homeobox and Zinc Finger Factors

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Hagman, Ragnvi ^a   Rönnberg, Elin ^a   Pejler, Gunnar ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE; ZINC FINGER PROTEIN;

ANIMAL; ARTICLE; BACTERIAL INFECTION; CELL ADHESION; DNA MICROARRAY; DOG; FEMALE; GENE EXPRESSION PROFILING; INFLAMMATION; METABOLISM; MICROBIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERUS; UTERUS DISEASE;

ANIMALS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CELL ADHESION; CHEMOKINES; CYTOKINES; DOGS; FEMALE; GENE EXPRESSION PROFILING; INFLAMMATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTERINE DISEASES; UTERUS; ZINC FINGERS;

EID: 77951246290     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008039     Document Type: Article

References (56)

1. Parrillo JE, (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471-1477.
2. Vincent JL, Abraham E, (2006) The last 100 years of sepsis. Am J Respir Crit Care Med 173: 256-263.
3. Vincent JL, (2000) Update on sepsis: pathophysiology and treatment. Acta Clin Belg 55: 79-87.
4. Llewelyn M, Cohen J, (2001) Diagnosis of infection in sepsis. Intensive Care Med 27 (Suppl 1): S10-32.
5. Tang BM, Eslick GD, Craig JC, McLean AS, (2007) Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7: 210-217.
6. Marshall JC, Reinhart K, (2009) Biomarkers of sepsis. Crit Care Med 37: 2290-2298.
7. Vandijck DM, Blot SI, Decruyenaere JM, (2008) Update on the management of infection in patients with severe sepsis. Dimens Crit Care Nurs 27: 244-248.
8. Poli-de-Figueiredo LF, Garrido AG, Nakagawa N, Sannomiya P, (2008) Experimental models of sepsis and their clinical relevance. Shock 30 (Suppl 1): 53-59.
9. Higgins MA, Berridge BR, Mills BJ, Schultze AE, Gao H, et al.(2003) Gene expression analysis of the acute phase response using a canine microarray. Toxicol Sci 74: 470-484.
10. Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe DB, et al.(2005) Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 438: 803-819.
11. Egenvall A, Hagman R, Bonnett BN, Hedhammar A, Olson P, et al.(2001) Breed risk of pyometra in insured dogs in Sweden. J Vet Intern Med 15: 530-538.
12. Hagman R, Greko C, (2005) Antimicrobial resistance in Escherichia coli isolated from bitches with pyometra and from urine samples from other dogs. Vet Rec 157: 193-196.
13. Brady CA, Otto CM, (2001) Systemic inflammatory response syndrome, sepsis, and multiple organ dysfunction. Vet Clin North Am Small Anim Pract 31: 1147-1162, v-vi.
14. Hagman R, Kindahl H, Fransson BA, Bergstrom A, Holst BS, et al.(2006) Differentiation between pyometra and cystic endometrial hyperplasia/mucometra in bitches by prostaglandin F2alpha metabolite analysis. Theriogenology 66: 198-206.
15. Hagman R, Kindahl H, Lagerstedt AS, (2006) Pyometra in bitches induces elevated plasma endotoxin and prostaglandin F2alpha metabolite levels. Acta Vet Scand 47: 55-67.
16. Martin CM, Priestap F, Fisher H, Fowler RA, Heyland DK, et al.(2009) A prospective, observational registry of patients with severe sepsis: the Canadian Sepsis Treatment and Response Registry. Crit Care Med 37: 81-88.
17. Granstrom E, Kindahl H, (1982) Radioimmunoassay of the major plasma metabolite of PGF2 alpha, 15-keto-13,14-dihydro-PGF2 alpha. Methods Enzymol 86: 320-339.
18. Wensman H, Goransson H, Leuchowius KJ, Stromberg S, Ponten F, et al.(2008) Extensive expression of craniofacial related homeobox genes in canine mammary sarcomas. Breast Cancer Res Treat.
19. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al.(2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
20. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
21. Hochberg Y, Benjamini Y, (1990) More powerful procedures for multiple significance testing. Stat Med 9: 811-818.
22. Sturn A, Quackenbush J, Trajanoski Z, (2002) Genesis: cluster analysis of microarray data. Bioinformatics 18: 207-208.
23. Hauptman JG, Walshaw R, Olivier NB, (1997) Evaluation of the sensitivity and specificity of diagnostic criteria for sepsis in dogs. Vet Surg 26: 393-397.
24. Raymond WW, Sommerhoff CP, Caughey GH, (2005) Mastin is a gelatinolytic mast cell peptidase resembling a mini-proteasome. Arch Biochem Biophys 435: 311-322.
25. Lindahl U, (1999) What else can 'Heparin' do? Haemostasis 29 (Suppl S1): 38-47.
26. Houston G, Cuthbertson BH, (2009) Activated protein C for the treatment of severe sepsis. Clin Microbiol Infect 15: 319-324.
27. Gupta S, Singh RK, Dastidar S, Ray A, (2008) Cysteine cathepsin S as an immunomodulatory target: present and future trends. Expert Opin Ther Targets 12: 291-299.
28. Godinez I, Raffatellu M, Chu H, Paixao TA, Haneda T, et al.(2009) Interleukin-23 orchestrates mucosal responses to Salmonella enterica serotype Typhimurium in the intestine. Infect Immun 77: 387-398.
29. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, et al.(2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14: 282-289.
30. Canny G, Levy O, (2008) Bactericidal/permeability-increasing protein (BPI) and BPI homologs at mucosal sites. Trends Immunol 29: 541-547.
31. Cole AM, Ganz T, Liese AM, Burdick MD, Liu L, et al.(2001) Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity. J Immunol 167: 623-627.
32. Maerki C, Meuter S, Liebi M, Muhlemann K, Frederick MJ, et al.(2009) Potent and broad-spectrum antimicrobial activity of CXCL14 suggests an immediate role in skin infections. J Immunol 182: 507-514.
33. Ceron JJ, Eckersall PD, Martynez-Subiela S, (2005) Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet Clin Pathol 34: 85-99.
34. Fransson BA, Bergstrom A, Wardrop KJ, Hagman R, (2007) Assessment of three automated assays for C-reactive protein determination in dogs. Am J Vet Res 68: 1281-1286.
35. Schenck M, Carpinteiro A, Grassme H, Lang F, Gulbins E, (2007) Ceramide: physiological and pathophysiological aspects. Arch Biochem Biophys 462: 171-175.
36. Dyson A, Singer M, (2009) Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit Care Med 37: S30-37.
37. Johnson SB, Lissauer M, Bochicchio GV, Moore R, Cross AS, et al.(2007) Gene expression profiles differentiate between sterile SIRS and early sepsis. Ann Surg 245: 611-621.
38. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC, (2009) Gene-expression profiling of peripheral blood mononuclear cells in sepsis. Crit Care Med 37: 882-888.
39. Wong HR, Cvijanovich N, Allen GL, Lin R, Anas N, et al.(2009) Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 37: 1558-1566.
40. Arend WP, Palmer G, Gabay C, (2008) IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 223: 20-38.
41. Overall CM, McQuibban GA, Clark-Lewis I, (2002) Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics. Biol Chem 383: 1059-1066.
42. Li J, Yuan J, (2008) Caspases in apoptosis and beyond. Oncogene 27: 6194-6206.
43. Lakshmanan U, Porter AG, (2007) Caspase-4 interacts with TNF receptor-associated factor 6 and mediates lipopolysaccharide-induced NF-kappaB-dependent production of IL-8 and CC chemokine ligand 4 (macrophage-inflammatory protein-1). J Immunol 179: 8480-8490.
44. Maelfait J, Beyaert R, (2008) Non-apoptotic functions of caspase-8. Biochem Pharmacol 76: 1365-1373.
45. LeBlanc PM, Yeretssian G, Rutherford N, Doiron K, Nadiri A, et al.(2008) Caspase-12 modulates NOD signaling and regulates antimicrobial peptide production and mucosal immunity. Cell Host Microbe 3: 146-157.
46. Vasiljeva O, Reinheckel T, Peters C, Turk D, Turk V, et al.(2007) Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr Pharm Des 13: 387-403.
47. Porter S, Clark IM, Kevorkian L, Edwards DR, (2005) The ADAMTS metalloproteinases. Biochem J 386: 15-27.
48. Edwards DR, Handsley MM, Pennington CJ, (2008) The ADAM metalloproteinases. Mol Aspects Med 29: 258-289.
49. Pejler G, Abrink M, Wernersson S, (2009) Serglycin proteoglycan: regulating the storage and activities of hematopoietic proteases. Biofactors 35: 61-68.
50. Niemann CU, Abrink M, Pejler G, Fischer RL, Christensen EI, et al.(2007) Neutrophil elastase depends on serglycin proteoglycan for localization in granules. Blood 109: 4478-4486.
51. Christensen KL, Patrick AN, McCoy EL, Ford HL, (2008) The six family of homeobox genes in development and cancer. Adv Cancer Res 101: 93-126.
52. Trivedi CM, Patel RC, Patel CV, (2007) Homeobox gene HOXA9 inhibits nuclear factor-kappa B dependent activation of endothelium. Atherosclerosis 195: e50-60.
53. Calon A, Gross I, Lhermitte B, Martin E, Beck F, et al.(2007) Different effects of the Cdx1 and Cdx2 homeobox genes in a murine model of intestinal inflammation. Gut 56: 1688-1695.
54. Kajiwara Y, Akram A, Katsel P, Haroutunian V, Schmeidler J, et al.(2009) FE65 binds Teashirt, inhibiting expression of the primate-specific caspase-4. PLoS ONE 4: e5071.
55. Hong JW, Allen CE, Wu LC, (2003) Inhibition of NF-kappaB by ZAS3, a zinc-finger protein that also binds to the kappaB motif. Proc Natl Acad Sci U S A 100: 12301-12306.
56. Moroy T, Zeng H, Jin J, Schmid KW, Carpinteiro A, et al.(2008) The zinc finger protein and transcriptional repressor Gfi1 as a regulator of the innate immune response. Immunobiology 213: 341-352.